Liraglutide Versus Exenatide Once Weekly_ Persistence, Adherence, and Early Discontinuation
Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial | Scientific Reports
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art - ScienceDirect
Liraglutide Achieves A1C Targets More often than Sitagliptin or Exenatide when Added to Metformin in Patients with Type 2 Diabetes and a Baseline A1C <8.0% - Endocrine Practice
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Cla
A1C Data | BYDUREON BCise® (exenatide extended-release) injectable suspension 2 mg | For HCPs
Abstract 13242: Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLinkTM Database | Circulation
Exenatide Effects on Glycemic Control in Type 2 Diabetes
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial | Nature Communications
Fasting plasma c-peptide level predicts the response of glucagon-like peptide-1 agonist (exenatide) add on to metformin monother
Table 1 from Exenatide ( Byetta ) , an Incretin Mimetic : The First in a New Therapeutic Class in the Treatment of Diabetes | Semantic Scholar
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes | Cardiovascular Diabetology | Full Text
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - ScienceDirect
Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial - Media Centre | EASD
Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes | Diabetes Technology & Therapeutics
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice
DATA SHEET
Efficacy and Safety of Exenatide versus Insulin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
Table 2 from Exenatide ( Byetta ) , an Incretin Mimetic : The First in a New Therapeutic Class in the Treatment of Diabetes | Semantic Scholar
Estimated average daily usage and cost of exenatide BiD and liraglutide... | Download Table
Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes - Watanabe - 2020 - Journal of Diabetes Investigation - Wiley Online Library
Simulated progression of HbA1c in exenatide BID þ OAD (treatment arm)... | Download Scientific Diagram
Overview of clinical trials comparing liraglutide qd with exenatide... | Download Table
Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin- exenatide study | BMC
ADA: Efficacy and Safety of Lixisenatide Once-Daily vs. Exenatide Twice-Daily in Type 2 DM Inadequately Controlled on Metformin (GetGoal-X)
